| PERIOD ENDING | 1-Nov-09 | 2-Aug-09 | 3-May-09 | 1-Feb-09 | | Total Revenue | 49,715 | 45,478 | 47,762 | 44,591 | | Cost of Revenue | 40,582 | 37,891 | 39,407 | 38,844 | | | Gross Profit | 9,133 | 7,587 | 8,355 | 5,747 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 5,385 | 4,895 | 5,253 | 4,675 | | Non Recurring | (185) | (158) | 33 | 402 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 3,933 | 2,850 | 3,069 | 670 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (87) | (502) | (236) | (9) | | Earnings Before Interest And Taxes | 3,846 | 2,348 | 2,833 | 661 | | Interest Expense | 342 | 357 | 620 | 644 | | Income Before Tax | 3,504 | 1,991 | 2,213 | 17 | | Income Tax Expense | 625 | 115 | 517 | 467 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 2,879 | 1,876 | 1,696 | (450) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 2,879 | 1,876 | 1,696 | (450) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $2,879 | $1,876 | $1,696 | ($450) |
|
0.02% Nasdaq 
0.44%
Income Statement
